Time for another shameless plug. The 31st Annual ACI Drug & Medical Device Litigation Conference takes place December 2–3, 2026 at the New York Marriott Marquis, and several of our Reed Smith bloggers are planning to be there. The full agenda is here.
We’re especially pleased that our own Lisa Baird is speaking on “Putting the Offense in the Preemption Defense” – exploring whether the time has come to go on the offense with preemption, including leveraging the Supreme Court’s FIFRA opinion in Monsanto v. Durnell and whether the reasoning in Medtronic v. Lohr has finally been undermined enough for courts to take notice.
The conference features 75+ speakers, including in-house leaders from Medtronic, Bristol-Myers Squibb, Novo Nordisk, Johnson & Johnson, Gilead Sciences, and many more, alongside top defense firms and members of the judiciary. The conversations you have here can genuinely shift your practice.
ACI has once again invited the blog to serve as a media sponsor, and they’re offering our readers a special 10% discount on registration. Just be sure to use the code D10-999-DDLB27 when you sign up.
You can register here. We hope to see you in New York!